EMA’s CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma July 21, 2017October 21, 2019 by / Share This.....LinkedinTwitterFacebookGoogleEmailDownload PDF Related News: CHMP recommends EU approval of Roche’s Tecentriq as…Rakuten Medical and Shimadzu Enroll First Patient in…European Commission approves Roche’s Gavreto…SHIMADZU and SHIONOGI establishes joint venture…Osaka University, Shimadzu, and SIGMAXYZ Collaborate…Student Innovators From 51 Countries Compete to…
